Habitat escalated adaptive therapy (HEAT): a phase 2 trial utilizing radiomic habitat-directed and genomic-adjusted radiation dose (GARD) optimization for high-grade soft tissue sarcoma.

Autor: Naghavi, Arash O.1 (AUTHOR) Arash.Naghavi@moffitt.org, Bryant, J. M.1 (AUTHOR), Kim, Youngchul2 (AUTHOR), Weygand, Joseph3 (AUTHOR), Redler, Gage1 (AUTHOR), Sim, Austin J.4 (AUTHOR), Miller, Justin1 (AUTHOR), Coucoules, Kaitlyn1 (AUTHOR), Michael, Lauren Taylor5 (AUTHOR), Gloria, Warren E.6 (AUTHOR), Yang, George1 (AUTHOR), Rosenberg, Stephen A.1 (AUTHOR), Ahmed, Kamran1 (AUTHOR), Bui, Marilyn M.6 (AUTHOR), Henderson-Jackson, Evita B.6 (AUTHOR), Lee, Andrew1 (AUTHOR), Lee, Caitlin D.1 (AUTHOR), Gonzalez, Ricardo J.7 (AUTHOR), Feygelman, Vladimir1 (AUTHOR), Eschrich, Steven A.2 (AUTHOR)
Zdroj: BMC Cancer. 4/9/2024, Vol. 24 Issue 1, p1-16. 16p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje